NCT Number: NCT03984734
Quality of Life and Nutritional Status After Two Surgical Techniques in Pancreatoduodenectomy
This was a randomized unblinded single-centre trial. The main hypothesis of the study was that pylorus-preserving pancreatoduodenectomy reduces the incidence of delayed gastric emptying . Patients undergoing pancreatoduodenectomy were randomized to undergo one of two types of surgical technique: pylorus-preserving pancreatoduodenectomy versus stardard pancreatoduodenectomy with antrectomy. The primary endpoint was the incidence and severity of delayed gastric emptying. Secondary endpoints were postoperative morbidity and mortality, length of hospital stay, and nutritional status and quality of life.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
This was a randomized unblinded single-centre trial without masked evaluation of the main outcome.The authors decided to compare pancreatoduodenectomy with antrectomy versus pancreatoduodenectomy with pyloric preservation. The primary aim of this randomized clinical trial was to determine whether pancreatoduodenectomy with pyloric preservation is associated with a lower incidence and severity of delayed gastric emptying. Secondary endpoints were postoperative complications, postoperative mortality and duration of hospital stay. Patients undergoing pancreatoduodenectomy were randomized to undergo one of two types of gastroenteric anastomosis for reconstruction. Analytical parameters such as C-reactive protein, prealbumin, and albumin; as well as anthropometric measures (mean) as preoperative arm circumference mean and tricipital skinfold mean were registered preoperatively, at 5th week, and at 6th mounth. Scintigraphic study had performed following a specific protocol for gastric emptying. At the end, quality of life was also analized with a quality of life questionnaire (QLPAN26) preoperativelly and postoperatively.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients who underwent surgical resection of the head of the pancreas at the authors' institution from August 2003 to August 2008. Adults of either sex aged over 18 years were included.
Exclusion criteria
- Associated resections of other organs, except for the portal or superior mesenteric vein
- Total pancreatectomy
- Previous gastrectomy or other gastric surgeries
- Neoadjuvant treatment
- Liver cirrhosis.
Treatment and study plan
Pylorus-preserving pancreatoduodenectomy
ProcedurePrimary outcomes
-
Incidence and severity of DGE
Time frame: within the first 90 days after surgery
Nasogastric tube not removed before the 10th postoperative days or if liquids were not tolerated before the 14th postoperative day
Secondary outcomes
-
Postoperative morbidity
Time frame: within the first 90 days after surgery
Appearance of any complication during the hospital stay
-
Postoperative mortality
Time frame: within the first 90 days after surgery
Any death that happens during the hospital admission or within 90 days after surgery
-
Length of hospital stay
Time frame: within the first 90 days after surgery
Postoperative hospital stay after pancreatoduodenectomy
Sponsors and collaborators
Lead sponsor
Hospital Universitari de Bellvitge
Other
Registry information
Official study title
Randomized Trial Comparing Quality of Life and Nutritional Status Between Pylorus-preserving Pancreatoduodenectomy Versus Standard Pancreatoduodenectomy (QUANUPAD TRIAL)
Acronym: QUANUPAD
Important dates
- Study start
- 2003
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Jun 13, 2019
- Registry last updated
- Jun 13, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Effect of taVNS on the Prognosis of Patients Undergoing Pancreatoduodenectomy
NCT06786923
Delayed Gastric Emptying, Digestive System Diseases
Nantong, Jiangsu, China
View Trial DetailsUsing Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.
NCT06038734
Delayed Gastric Emptying, Digestive System Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNasogastric Decompression Following Pancreaticoduodenectomy
NCT06413888
Delayed Gastric Emptying, Digestive System Diseases
Houston, Texas, United States
View Trial DetailsEvaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron
NCT05342818
Delayed Gastric Emptying, Digestive System Diseases
Sharurah, Saudi Arabia
View Trial Details